Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hsiang-Kuang Tseng & John R Perfect. (2011) Strategies to manage antifungal drug resistance. Expert Opinion on Pharmacotherapy 12:2, pages 241-256.
Read now
Read now
Alex P. Betrosian, Frantzeska Frantzeskaki, Anna Xanthaki & George Georgiadis. (2007) High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii. Scandinavian Journal of Infectious Diseases 39:1, pages 38-43.
Read now
Read now
Articles from other publishers (27)
Simone Giuliano, Francesco Sbrana & Carlo Tascini. (2023) Sulbactam–durlobactam for infections caused by Acinetobacter baumannii–calcoaceticus complex. The Lancet Infectious Diseases 23:8, pages e274.
Crossref
Crossref
X. Wu, G. Zhong, H. Wang & J. Zhu. (2023) Temporal association between antibiotic use and resistance in Gram-negative bacteria. Brazilian Journal of Biology 83.
Crossref
Crossref
Francesca Paola Nocera, Anna-Rita Attili & Luisa De Martino. (2021) Acinetobacter baumannii: Its Clinical Significance in Human and Veterinary Medicine. Pathogens 10:2, pages 127.
Crossref
Crossref
Yingying Hao, Shixing Chen, Haiyan Chang, Xiaomin Yan, Wanqing Zhou, Xiaoli Cao, Rui Huang, Zhaoping Zhang, Haixia Zhang, Bei Jia, Weihua Wu, Yali Xiong, Yuxin Chen & Chao Wu. (2020) Temporal association between carbapenems usage and antimicrobial resistance in gram-negative bacteria at a tertiary hospital in Nanjing, China. Diagnostic Microbiology and Infectious Disease 98:2, pages 115083.
Crossref
Crossref
Paúl Alexis López-Durán, Salvador Fonseca-Coronado, Lucila Maritza Lozano-Trenado, Sergio Araujo-Betanzos, Deniria Alejandra Rugerio-Trujillo, Gilberto Vaughan & Elsa Saldaña-Rivera. (2020) Nosocomial transmission of extensively drug resistant Acinetobacter baumannii strains in a tertiary level hospital. PLOS ONE 15:4, pages e0231829.
Crossref
Crossref
Adrian Schmid, Aline Wolfensberger, Johannes Nemeth, Peter W. Schreiber, Hugo Sax & Stefan P. Kuster. (2019) Monotherapy versus combination therapy for multidrug-resistant Gram-negative infections: Systematic Review and Meta-Analysis. Scientific Reports 9:1.
Crossref
Crossref
Kirati Kengkla, Khachen Kongpakwattana, Surasak Saokaew, Anucha Apisarnthanarak & Nathorn Chaiyakunapruk. (2018) Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis. Journal of Antimicrobial Chemotherapy 73:1, pages 22-32.
Crossref
Crossref
Haojun Chen, Qianqian Liu, Zhanguo Chen & Congrong Li. (2017) Efficacy of sulbactam for the treatment of Acinetobacter baumannii complex infection: A systematic review and meta-analysis. Journal of Infection and Chemotherapy 23:5, pages 278-285.
Crossref
Crossref
Shio-Shin Jean, Tai-Chin Hsieh, Chin-Wan Hsu, Wen-Sen Lee, Kuan-Jen Bai & Carlos Lam. (2016) Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests. Journal of Microbiology, Immunology and Infection 49:6, pages 924-933.
Crossref
Crossref
P. Poulikakos, G. S. Tansarli & M. E. Falagas. (2014) Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review. European Journal of Clinical Microbiology & Infectious Diseases 33:10, pages 1675-1685.
Crossref
Crossref
Khalid Ahmed Al-Anazi & Asma M. Al-Jasser. (2014) Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation. Frontiers in Oncology 4.
Crossref
Crossref
Haiqing Chu, Lan Zhao, Minggui Wang, Yang Liu, Tao Gui & Jingbo Zhang. (2013) Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis. The Brazilian Journal of Infectious Diseases 17:4, pages 389-394.
Crossref
Crossref
Robertino M. MeraLinda A. MillerHeather Amrine-MadsenDaniel F. Sahm. (2010)
Acinetobacter baumannii
2002–2008: Increase of Carbapenem-Associated Multiclass Resistance in the United States
. Microbial Drug Resistance 16:3, pages 209-215.
Crossref
Crossref
José Garnacho-Montero & Rosario Amaya-Villar. (2010) Multiresistant Acinetobacter baumannii infections: epidemiology and management. Current Opinion in Infectious Diseases 23:4, pages 332-339.
Crossref
Crossref
Murat Dizbay, Derya Keten Tozlu, Meltem Yalinay Cirak, Yasemin Isik, Kevser Ozdemir & Dilek Arman. (2009) In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii. The Journal of Antibiotics 63:2, pages 51-53.
Crossref
Crossref
Drosos E Karageorgopoulos & Matthew E Falagas. (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. The Lancet Infectious Diseases 8:12, pages 751-762.
Crossref
Crossref
Po-Chin Chi, Chien-Liang Wu, Chung-Lieh Hung, Yu-Ling Weng, Ching-Chi Lin & Shih-Yi Lee. (2008) The Experience of a Novel Glycylcycline Antibiotic for a Patient with Infection Caused by Multiple Drug-Resistant Pathogens: What is the Benefit?. International Journal of Gerontology 2:3, pages 124-127.
Crossref
Crossref
Po-Liang Lu, Li-Yueh Huang, Shen-Tsuen Lian, Ko Chang, Chun-Lu Lin, In-Jane Hwang, Wen-Gin Chiang, Yen-Hsu Chen, Sheng-Fung Lin & L.K. Siu. (2008) How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital. International Journal of Antimicrobial Agents 31:5, pages 463-466.
Crossref
Crossref
Yu-Chen Tseng, Jann-Tay Wang, Fe-Lin Lin Wu, Yee-Chun Chen, Wei-Chu Chie & Shan-Chwen Chang. (2007) Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii. Diagnostic Microbiology and Infectious Disease 59:2, pages 181-190.
Crossref
Crossref
Chun-Hsing Liao, Wang-Huei Sheng, Yee-Chun Chen, Chien-Ching Hung, Jann-Tay Wang & Shan-Chwen Chang. (2007) Predictive value of the serum bactericidal test for mortality in patients infected with multidrug-resistant Acinetobacter baumannii. Journal of Infection 55:2, pages 149-157.
Crossref
Crossref
Filipe Froes, José Artur Paiva, Piedade Amaro, João Pedro Baptista, Gabriela Brum, Henrique Bento, Paula Duarte, Conceição Sousa Dias, Carlos Glória, Helena Estrada, Luís Telo, Eduardo Silva, João Gonçalves Pereira & Germano do Carmo. (2007) Consensus document on nosocomial pneumonia. Revista Portuguesa de Pneumologia (English Edition) 13:3, pages 419-486.
Crossref
Crossref
Filipe Froes, José Artur Paiva, Piedade Amaro, João Pedro Baptista, Gabriela Brum, Henrique Bento, Paula Duarte, Conceição Sousa Dias, Carlos Glória, Helena Estrada, Luís Telo, Eduardo Silva, João Gonçalves Pereira & Germano do Carmo. (2007) Documento de Consenso sobre pneumonia nosocomial11Sociedade Portuguesa de Pneumologia e Sociedade Portuguesa de Cuidados Intensivos / Portuguese Society of Pulmonology and Intensive Care Society,22O presente documento é simultaneamente publicado na Revista Portuguesa de Medicina Intensiva (2007; 14(1):7-30) / This work is published simultaneously in the Portuguese Journal of Intensive Care Medicine (2007; 14(1):7-30). Revista Portuguesa de Pneumologia 13:3, pages 419-486.
Crossref
Crossref
Ki Tae Kwon, Won Sup Oh, Jae-Hoon Song, Hyun-Ha Chang, Sook-In Jung, Shin-Woo Kim, Seong Yeol Ryu, Sang Taek Heo, Dong Sik Jung, Ji-Young Rhee, Sang Yop Shin, Kwan Soo Ko, Kyong Ran Peck & Nam Yong Lee. (2007) Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. Journal of Antimicrobial Chemotherapy 59:3, pages 525-530.
Crossref
Crossref
Min-Nan Hung, Po-Ren Hsueh, Hou-Tai Chang, Wen-Sen Lee, Ming-Yuan Chou, Ing-Shen Chen, Jen-Hsien Wang, Chen-Fu Lin, Jainn-Ming Shyr, Wen-Chien Ko, Jiunn-Jong Wu, Yung-Ching Liu, Wen-Kuei Huang, Lee-Jene Teng, Cheng-Yi Liu & Kwen-Tay Luh. (2007) In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data. International Journal of Antimicrobial Agents 29:2, pages 145-152.
Crossref
Crossref
Matthew E. Falagas, Patra K. Koletsi & Ioannis A. Bliziotis. (2006) The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. Journal of Medical Microbiology 55:12, pages 1619-1629.
Crossref
Crossref
José Miguel Cisneros-Herreros, José Garnacho-Montero & M. Eugenia Pachón-Ibáñez. (2005) Neumonía nosocomial por Acinetobacter baumannii. Enfermedades Infecciosas y Microbiología Clínica 23, pages 46-51.
Crossref
Crossref
M.E. Falagas & S.K. Kasiakou. (2005) Correct use of the term ‘pan-drug-resistant’ (PDR) Gram-negative bacteria. Clinical Microbiology and Infection 11:12, pages 1049-1050.
Crossref
Crossref